240 related articles for article (PubMed ID: 4386574)
21. Characteristics of a family with the MEN-2A syndrome.
Haak HR; Nieuwenhuijzen Kruseman AC
Henry Ford Hosp Med J; 1987; 35(2-3):104-6. PubMed ID: 2891639
[No Abstract] [Full Text] [Related]
22. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
23. Gene probe analysis in an informative family with multiple endocrine neoplasia syndrome type 2A (MEN 2A). Improvement in carrier risk estimation.
Morrison PJ; Hadden DR; Hughes AE; Kennedy L; Russell CJ; Nevin NC
Q J Med; 1991 Jul; 80(291):597-603. PubMed ID: 1682970
[TBL] [Abstract][Full Text] [Related]
24. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
25. Myotonic dystrophy and hyperparathyroidism: association with neurofibromatosis and multiple endocrine adenomatosis type 2A.
Rosenberg NL; Diliberti JH; Andrews AM; Buist NR
J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1578-80. PubMed ID: 2906090
[TBL] [Abstract][Full Text] [Related]
26. [Bilateral pheochromocytoma-medullary carcinoma of the thyroid gland with Cushing's syndrome].
Mathys S; Ziegler WH; Francke C
Schweiz Med Wochenschr; 1972 Jun; 102(23):798-803. PubMed ID: 5067812
[No Abstract] [Full Text] [Related]
27. [Familial medullary carcinoma of the thyroid].
Calderón MD; Angel M; Cabrer J; Palacín A; Rabasseda J; Vilardell E
Med Clin (Barc); 1984 Jan; 82(2):71-3. PubMed ID: 6142988
[No Abstract] [Full Text] [Related]
28. [A family with type 2a multiple endocrine neoplasms].
Haak HR; Vierhout PA; Vink M; Nieuwenhuyzen Kruseman AC
Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1660-4. PubMed ID: 2902520
[No Abstract] [Full Text] [Related]
29. Multiple endocrine adenomatosis type II (Sipple's syndrome) in twins.
Reza MJ; Young RT; Van Herle AJ; DeQuattro V; Cole HS; Brown J
West J Med; 1975 Dec; 123(6):441-6. PubMed ID: 1199100
[TBL] [Abstract][Full Text] [Related]
30. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
[TBL] [Abstract][Full Text] [Related]
31. Familial pheochromocytoma, medullary thyroid carcinoma, and parathyroid adenomas.
Paloyan E; Scanu A; Straus FH; Pickleman JR; Paloyan D
JAMA; 1970 Nov; 214(8):1443-7. PubMed ID: 5536344
[No Abstract] [Full Text] [Related]
32. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up.
Howe JR; Norton JA; Wells SA
Surgery; 1993 Dec; 114(6):1070-7. PubMed ID: 7903003
[TBL] [Abstract][Full Text] [Related]
33. [Sipple's syndrome: pheochromocytoma and thyroid cancer of the medullary type (amyloid formation). Familial form].
Tcherdakoff P; Juillet Y; Gaudart d'Allaines C; Camilieri JP
Ann Med Interne (Paris); 1974 Nov; 125(11):855-61. PubMed ID: 4460829
[No Abstract] [Full Text] [Related]
34. [Multiple endocrine adenomatosis type II-a: presentation of a stricken family].
García H; Pou J; Moreiro J
Med Clin (Barc); 1987 May; 88(17):689-92. PubMed ID: 2886708
[No Abstract] [Full Text] [Related]
35. Animal model of human disease. Medullary thyroid carcinoma, multiple endocrine neoplasia, Sipple's syndrome. Animal model: ultimobranchial thyroid neoplasm in the bull.
Capen CC; Black HE
Am J Pathol; 1974 Feb; 74(2):377-80. PubMed ID: 4811759
[No Abstract] [Full Text] [Related]
36. Multiple endocrine neoplasia, type II: a combined surgical and genetic approach to treatment.
Partington MW; Ghent WR; Sears EV; Simpson NE
Can Med Assoc J; 1981 Feb; 124(4):403-10. PubMed ID: 7214269
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in calcium metabolism: application to medullary carcinoma of the thyroid and hyperparathyroidism.
Kaplan EL
Surg Annu; 1973; 5():97-119. PubMed ID: 4602211
[No Abstract] [Full Text] [Related]
38. Multiple endocrine neoplasia type IIb: a description of several patients and review of the literature.
Montgomery TB; Mandelstam P; Tachman ML; Miller RE; Powell DE; Flueck JA; Kotchen TA
J Clin Hypertens; 1987 Mar; 3(1):31-49. PubMed ID: 2883264
[TBL] [Abstract][Full Text] [Related]
39. [Multiple endocrine neoplasm type II-A].
Díaz de Greñu Martínez C; Menéndez Torre EL; Boix Pallarés P; Aller Granda J; Díaz Cadorniga FJ; Rabal Artal A
Med Clin (Barc); 1985 Nov; 85(18):756-8. PubMed ID: 2869204
[No Abstract] [Full Text] [Related]
40. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
